机译:在总甲状腺切除术后乳头状甲状腺癌患者的第一个I-131放射治疗的影响因素
Zhejiang Chinese Med Univ Hangzhou 310053 Zhejiang Peoples R China;
Hangzhou First Peoples Hosp Hangzhou Canc Hosp Dept Nucl Med Hangzhou 310002 Zhejiang Peoples;
Hangzhou First Peoples Hosp Hangzhou Canc Hosp Dept Nucl Med Hangzhou 310002 Zhejiang Peoples;
Hangzhou First Peoples Hosp Hangzhou Canc Hosp Dept Nucl Med Hangzhou 310002 Zhejiang Peoples;
Hangzhou First Peoples Hosp Hangzhou Canc Hosp Dept Nucl Med Hangzhou 310002 Zhejiang Peoples;
Hangzhou First Peoples Hosp Hangzhou Canc Hosp Dept Nucl Med Hangzhou 310002 Zhejiang Peoples;
Hangzhou First Peoples Hosp Dept Tumor Surg Hangzhou 310006 Zhejiang Peoples R China;
Zhejiang Chinese Med Univ Hangzhou 310053 Zhejiang Peoples R China;
Papillary thyroid carcinoma; Radioiodine-131; Thyroglobulin level; Lymph node metastasis; Treatment outcome;
机译:在总甲状腺切除术后乳头状甲状腺癌患者的第一个I-131放射治疗的影响因素
机译:全甲状腺切除术中国患者乳头状甲状腺癌复发的危险因素分析
机译:全甲状腺切除术后PET / CT上F-18 FDG的亲和力和宫颈淋巴结的恶性形状可预测乳头状甲状腺癌患者对大剂量I-131治疗的耐药性
机译:乳头状甲状腺癌德尔菲淋巴结转移的影响因素及临床意义的研究
机译:甲状腺乳头状癌的免疫浸润。
机译:全甲状腺切除术后PET / CT上F-18 FDG的亲和力和宫颈淋巴结的恶性形状可预测乳头状甲状腺癌患者对大剂量I-131治疗的耐药性
机译:Hemi-thyroidomy与低风险乳头状甲状腺癌患者的总甲状腺切除术,大小2厘米或更少